A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma

Peter C Petersen*, Lone N Petersen, Ivan Vogelius, Jon K Bjerregaard, Lene Baeksgaard

*Corresponding author af dette arbejde

Fingeraftryk

Dyk ned i forskningsemnerne om 'A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science